| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.76▼ | 1.78▼ | 1.78▼ | 1.77▼ | 1.76▼ |
| MA10 | 1.78▼ | 1.79▼ | 1.79▼ | 1.77▼ | 1.94▼ |
| MA20 | 1.79▼ | 1.79▼ | 1.78▼ | 1.76▼ | 1.89▼ |
| MA50 | 1.79▼ | 1.79▼ | 1.79▼ | 2.02▼ | 2.00▼ |
| MA100 | 1.79▼ | 1.79▼ | 1.76▼ | 1.91▼ | 1.64▲ |
| MA200 | 1.79▼ | 1.76▼ | 1.83▼ | 1.95▼ | 1.58▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.005▼ | -0.003▼ | 0.017▲ | -0.034▼ |
| RSI | 10.501▼ | 34.115▼ | 37.906▼ | 41.471▼ | 46.226▼ |
| STOCH | 0.000▼ | 23.155 | 30.952 | 50.000 | 16.478▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -61.905 | -87.736▼ |
| CCI | -175.641▼ | -308.772▼ | -205.735▼ | 14.173 | -80.529 |
|
Wednesday, December 17, 2025 04:05 AM
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and commercialization of innovative therapeutics for rare diseases ...
|
|
Sunday, November 16, 2025 04:00 PM
Protalix BioTherapeutics, Inc. (NYSE:PLX) announced 3Q:25 financial and operational results in a November 13th, 2025, press release and in its Form 10-Q filing. The reports were followed by a ...
|
|
Sunday, October 26, 2025 08:00 AM
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Protalix BioTherapeutics, Inc. ("Protalix" or the "Company") (NYSE:PLX). Such ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/12/25 | 1.79 | 1.84 | 1.73 | 1.73 | 849,733 |
| 18/12/25 | 1.805 | 1.805 | 1.75 | 1.80 | 318,309 |
| 17/12/25 | 1.84 | 1.84 | 1.74 | 1.76 | 563,226 |
| 16/12/25 | 1.74 | 1.83 | 1.74 | 1.81 | 341,300 |
| 15/12/25 | 1.78 | 1.78 | 1.72 | 1.74 | 310,210 |
| 12/12/25 | 1.81 | 1.86 | 1.765 | 1.79 | 496,241 |
| 11/12/25 | 1.80 | 1.85 | 1.76 | 1.83 | 576,900 |
| 10/12/25 | 1.74 | 1.83 | 1.74 | 1.80 | 526,269 |
| 09/12/25 | 1.72 | 1.80 | 1.72 | 1.75 | 377,500 |
| 08/12/25 | 1.71 | 1.78 | 1.68 | 1.74 | 465,600 |
|
|
||||
|
|
||||
|
|